Penumbra Announces European Launch of its Most Advanced Neuro Access Offerings: BMX81 and BMX96

Penumbra announced the CE Mark and European launch of BMX™81 and BMX™96. These devices are designed for neurovascular management of ischemic and hemorrhagic stroke and are Penumbra’s most advanced neuro access offerings.

This announcement further expands the company’s neuro portfolio in Europe, following the news in early May when Penumbra launched three new RED™ reperfusion catheters (RED 43, RED 72 with SENDit™ Technology, and RED 78).

“Physicians in Europe now have more options to serve their patients using our expanded portfolio. With five innovative devices introduced in Europe in a matter of months, our dedication to improving stroke care enables us to provide physicians with customised stroke solutions,” said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra, Inc. “In all modesty, Penumbra provides physicians with the widest aspiration thrombectomy stroke portfolio on the market.”

Unlike traditional access catheters, Penumbra’s BMX81 and BMX96 are made using laser-cut stainless steel hypotube technology, offering stability and trackability. They are designed to allow physicians to easily navigate the brain’s complex anatomy and can be used from either a femoral or radial access approach (i.e. via groin or wrist). The stainless steel hypotube also allows for a larger inner diameter while maintaining a lower outer diameter without compromising support. This expands intraprocedural options in both ischemic and hemorrhagic stroke.

“I need to be able to trust that my access catheters can provide the stability that I need. The new BMX catheters promise excellent support. With their expanded inner diameters, I will be able to increase therapeutic options for my patients, especially when going radial,” said Dr. Markus Holtmannspötter, Head of Neuroradiology at Klinikum Nürnberg, Germany.

With 20 years of experience optimizing Science-Based Aspiration Thrombectomy (S-BAT), Penumbra’s catheters are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions and to navigate the challenging vasculature of the brain.

In Europe, stroke is a leading cause of death and adult disability affecting approx. 1.1 million people every year and causing 440,000 deaths¹. With the latest CE marked devices, Penumbra continues to offer the most expansive aspiration thrombectomy stroke portfolio on the market, now supported with the most advanced neuro access technologies available.

[1] Cardiovascular Disease Statistics 2023, Eurostat, https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_diseases Burden of Stroke in Europe, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382540/#R1

Important Safety Information 
Additional information about Penumbra’s products can be located on Penumbra’s website at 
www.penumbrainc.com/eu/products/neuro-access-catheters. Product availability varies by country. Caution: Federal (USA) law restricts these devices to sale by or on the order of a physician. Prior to use, please refer to Instructions for Use for complete product indications, contraindications, warnings, precautions, potential adverse events and detailed instructions for use. Risk information can be found at peninc.info/risk.